The Certificate in Psilocybin-Assisted Therapy is for therapists who wish to obtain the training and education necessary to become a licensed Psilocybin Facilitator under Oregon’s Measure 109. The program is grounded in Fluence’s Harm Reduction and Integration (PHRI) approach to psychedelic-assisted therapy and integration. It is designed and taught by leading experts with psilocybin-assisted therapy experience in clinical research settings. Fluence draws on a wealth of experience and resources to create this program with a new focus on community-based practice focus. Take this opportunity to learn about our program and bring your questions for our program leaders.
Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.
Victor Cabral, MSW, LSW, CCTP-I (He/Him/His) is a collaborative and strategic leader who has made an impact on human rights and historical inequalities throughout his career. Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor's Office of Advocacy and Reform where he helped lead the implementation of the Trauma-Informed PA Plan, establish the first Racial Day of Healing in Pennsylvania history, and developed free trauma trainings for Pennsylvanians in collaboration with internationally recognized experts. He is a research-based systems thinker with expertise in policy development, advocacy, consulting, racial and communal trauma, and is a practicing psychotherapist with training in Internal Family Systems, Psychedelic-Assisted Psychotherapy (MDMA and Ketamine), and other modalities. Victor was also listed on the Students for Sensible Drug Policy’s list of ’40 Under 40 Outstanding BIPOC Leaders in Drug Policy in the United States’ for his work in psychedelic policy.